ESC 365 - Prognostic importance of persistent elevations in high-sensitivity troponin T in the early convalescent phase (two weeks) following high-risk myocardial infarction: insights from the PARADISE-MI trial

ESC Professional Premium Access

Prognostic importance of persistent elevations in high-sensitivity troponin T in the early convalescent phase (two weeks) following high-risk myocardial infarction: insights from the PARADISE-MI trial

Session: Diagnostic and prognostic performance of cardiac troponin

Topic: Biomarkers

Speaker: Doctor K. Jering (Boston, US)

Event: ESC Congress 2024

Congress Presentation

Add to my library

About the speaker

Doctor Karola Jering

Brigham and Women's Hospital, Boston (United States of America)

0 follower

8 more presentations in this session

Troponin T as a risk marker for recurrent cardiovascular events in the post-discharge setting one month after acute coronary syndrome: a TRACER substudy

Speaker: Doctor C. Wassberg (Uppsala, SE)

High-sensitivity troponin T and risk of stroke in persons with suspected acute coronary syndrome

Speaker: Doctor M. Pareek (Copenhagen, DK)

Performance of a 99th percentile multiplier troponin score to predict in-hospital events and 1 year mortality in acute coronary syndrome

Troponin elevation during infection is associated with increased acute and long-term mortality

Fastidious adherence to 0/1-hour high-sensitivity troponin T testing reduces emergency department length of stay in patients presenting with suspected acute coronary syndromes.

Speaker: Miss G. Vimalaratnam (AU)

Access the full session

Diagnostic and prognostic performance of cardiac troponin

Speakers: Doctor K. Jering, Doctor C. Wassberg, Doctor M. Pareek, Miss G. Vimalaratnam

About the event

ESC Congress 2024

30 August - 2 September 2024

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources